Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-020819

Chief Scientific Officer sold 2,235 shares at an average $0.47 ($1,053)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Loose Christopher R. · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-13 Sale : show line 1 in the form 10b5-1 −1,329 $0.39 $518 198,358 D
2023-07-14 Sale : show line 2 in the form 10b5-1 −906 $0.59 $535 197,452 D
Open-market sales · 2,235 sh · avg $0.47 · $1,053
Loading xslF345X05/form4.xml…